Jesenwang, Germany

Stefan Hartle

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Jesenwang, DE (2013 - 2015)
  • Planegg, DE (2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Stefan Hartle: Innovator in Autoimmune Therapeutics**

Introduction

Stefan Hartle, an accomplished inventor based in Jesenwang, Germany, has made significant contributions to the field of biomedical innovations. With three patents to his name, his work primarily focuses on developing antibodies that target autoimmune and inflammatory disorders, showcasing his dedication to improving patient outcomes.

Latest Patents

One of Stefan Hartle's notable inventions is the development of Anti-IL12Rβ1 antibodies aimed at treating various autoimmune and inflammatory disorders. The invention specifically pertains to antibodies that bind to IL12Rβ1, the non-signal transducing chain of the heterodimeric IL12 and IL23 receptors. These antibodies function as antagonists capable of inhibiting IL12/IL18 induced IFNγ production from blood cells. This innovation offers potential therapeutic solutions for pathological disorders such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and other autoimmune conditions by targeting IL12 and IL23 signaling pathways.

Career Highlights

Stefan Hartle's professional journey has been closely associated with Novartis AG, where he has been able to leverage his research and development skills to advance therapeutic solutions. His expertise in antibody engineering and immunology has allowed him to contribute to the company's innovative pipeline, reflecting his commitment to addressing complex medical challenges.

Collaborations

Throughout his career, Stefan has collaborated with esteemed colleagues, including Christoph Heusser and Ingo Klagge. These partnerships have amplified the impact of his work and fostered an environment of creativity and scientific inquiry, leading to advancements in the field of immunotherapy.

Conclusion

As an inventor, Stefan Hartle has made substantial strides in the treatment of autoimmune and inflammatory disorders. Through his innovative patent developments at Novartis AG, he continues to pave the way for new therapeutic approaches that can significantly enhance the quality of life for patients suffering from these challenging conditions. His dedication to research and collaboration remains an inspiration in the world of biomedical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…